results

Corvus Pharmaceuticals to Announce Results from Cohort 4 of Placebo-Controlled Phase 1 Clinical Trial of Soquelitinib for Atopic Dermatitis

Company to host conference call and webcast on Tuesday, January 20, 2026 at 8:00 am ET / 5:00 am PT…

2 months ago

Bank of America Reports Fourth Quarter 2025 Financial Results

CHARLOTTE, N.C., Jan. 14, 2026 /PRNewswire/ -- Bank of America reported its fourth quarter 2025 financial results today. The news…

2 months ago

HUTCHMED Highlights Publication of Phase III SACHI Results in The Lancet

— First randomized Phase III trial confirming the efficacy of MET inhibition in patients with advanced NSCLC and acquired MET…

2 months ago

RxSight, Inc. Announces Preliminary Q4 and 2025 Financial Results; New Chief Financial Officer

January 11, 2026 09:30 ET  | Source: RxSight, Inc. ALISO VIEJO, Calif., Jan. 11, 2026 (GLOBE NEWSWIRE) -- (Nasdaq: RXST)…

2 months ago

Benitec Biopharma Provides Positive Long-Term Clinical Study Results for BB-301 Phase 1b/2a Clinical Trial Demonstrating Robust Efficacy and Continued Durability of Response

• Patient 1 of Cohort 1 has now completed the 24-month follow-up timepoint, and at month-24 post-treatment Patient 1 continued…

2 months ago

Varonis Announces Date of Fourth Quarter and Full-Year 2025 Financial Results

January 09, 2026 16:05 ET  | Source: Varonis Systems, Inc. MIAMI, Jan. 09, 2026 (GLOBE NEWSWIRE) -- Varonis Systems, Inc.…

2 months ago

Crinetics Pharmaceuticals to Provide PALSONIFY Business Update and Announce Topline Results from Fourth Cohort of Phase 2 Trial of Atumelnant in Congenital Adrenal Hyperplasia

January 04, 2026 16:00 ET  | Source: Crinetics Pharmaceuticals, Inc. SAN DIEGO, Jan. 04, 2026 (GLOBE NEWSWIRE) -- Crinetics Pharmaceuticals,…

2 months ago

Regeneron to Report Fourth Quarter and Full Year 2025 Financial and Operating Results and Host Conference Call and Webcast on January 30, 2026

January 02, 2026 16:05 ET  | Source: Regeneron Pharmaceuticals, Inc. TARRYTOWN, N.Y., Jan. 02, 2026 (GLOBE NEWSWIRE) -- Regeneron Pharmaceuticals,…

2 months ago

Immutable Holdings Announces Voting Results for its Annual General and Special Meeting of Shareholders

December 31, 2025 18:02 ET  | Source: Immutable Holdings Inc. VANCOUVER, British Columbia, Dec. 31, 2025 (GLOBE NEWSWIRE) -- Immutable…

2 months ago

TraceLink Earns Top-Tier ISO, SOC, and CyberVadis Results, Confirming Its Position as the Most Trusted Agentic Orchestration Platform for Life Sciences

Independent audits and a Platinum CyberVadis rating demonstrate the rigor, resilience, and maturity of the OPUS platform—the industry's secure, audit-ready…

2 months ago